Trial Outcomes & Findings for Spinal Cord Stimulation for Painful Diabetic Neuropathy (NCT NCT00487981)
NCT ID: NCT00487981
Last Updated: 2012-03-13
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE4
Target enrollment
1 participants
Primary outcome timeframe
6 months
Results posted on
2012-03-13
Participant Flow
Participant milestones
| Measure |
Spinal Cord Stimulation (SCS) Group
Spinal Cord Stimulation (SCS) Treatment Group
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Spinal Cord Stimulation (SCS) Group
Spinal Cord Stimulation (SCS) Treatment Group
|
|---|---|
|
Overall Study
Hypothyroidism diagnosis
|
1
|
Baseline Characteristics
Spinal Cord Stimulation for Painful Diabetic Neuropathy
Baseline characteristics by cohort
| Measure |
Spinal Cord Stimulation (SCS) Group
n=1 Participants
Spinal Cord Stimulation (SCS) Treatment Group
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
|
Age Continuous
|
59 years
STANDARD_DEVIATION 0 • n=99 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
1 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 6 monthsOutcome measures
Outcome data not reported
Adverse Events
Spinal Cord Stimulation (SCS) Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60